PBS Subsidy arrangements for insulin degludec and insulin aspart
Page last updated: 6 July 2023
The Department of Health and Aged Care has made amendments to the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021. This is following the issuance of the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Insulin Degludec and Insulin Aspart) Instrument 2023, which will allow pharmacists to supply different forms of injection insulin degludec and insulin aspart at equivalent doses for the duration of the shortage provided specified conditions are met. Further information about the substitution is available on the PBS Medicine Shortages page.